1.
|
Phase: Phase III, Phase II Type: Prevention Status: Closed Age: 45 to 75 Sponsor: NCI, Other Protocol IDs: 5 R01 CA098286-03, NCT00153816
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: NOVARTIS-4244603039
|
|
3.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 40 and over Sponsor: NCI, Other Protocol IDs: CDR0000068781, U10CA031946, CALGB-79809, NCI-P01-0184, NCT00022087
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N01C8, NCI-P02-0229, N01C8, NCT00043069
|
|
5.
|
Phase: Phase III Type: Treatment Status: Closed Age: postmenopausal Sponsor: Protocol IDs: CBCG-4400
|
|
6.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N02C1, N02C1, NCT00054418
|
|
7.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 40 to 55 Sponsor: Other Protocol IDs: 1769-03-A, CZOL446E, NCT00202059
|
|
8.
|
Phase: Phase III Type: Supportive care Status: Completed Age: Not specified Sponsor: Other Protocol IDs: BONEII, NCT00186901
|
|
9.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0518, 0518, NCT00329797
|
|
10.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0517, RTOG 0517, NCT00365105
|
|
11.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: ID03-0124, NCT00452439
|
|
12.
|
Phase: Phase III Type: Health services research, Natural history/Epidemiology, Prevention Status: Completed Age: 50 to 79 Sponsor: NCI, NHLBI Protocol IDs: 114, NCT00000611
|
|
13.
|
Phase: Phase III Type: Natural history/Epidemiology, Supportive care Status: Completed Age: 45 and over Sponsor: NCI, Other Protocol IDs: MA27B, CAN-NCIC-MA27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, CDR0000483099, NCIC-MA.27B, NCT00354302
|
|
14.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OXALI_L_03768, U1111-1116-9494, NCT01087658
|
|
15.
|
Phase: Phase II Type: Prevention Status: Closed Age: Over 18 Sponsor: NCI Protocol IDs: CPMC-IRB-6850, NCI-P97-0109
|
|
16.
|
Phase: Phase II Type: Prevention Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CPMC-IRB-94087, NCI-P97-0111
|
|
17.
|
Phase: Phase II Type: Prevention Status: Closed Age: 21 to 80 Sponsor: Protocol IDs: DMS-CALCIUM/CRC, NCI-P92-0017
|
|
18.
|
Phase: Phase II Type: Prevention Status: Closed Age: 30 to 74 Sponsor: NCI, Other Protocol IDs: 0126-2004, R01CA104637, NCT00208793
|
|
19.
|
Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 2005NT018, UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, UMN-2005NT018, NCT00321932
|
|
20.
|
Phase: Phase II Type: Natural history/Epidemiology, Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 6346, NCI-2010-00621, UWCC-6346, NOVARTIS-UWCC-6346, UWCC-06-2386-H/A, FHCRC-6346, NCT00416715
|
|
21.
|
Phase: Phase I Type: Prevention Status: Closed Age: 30 to 80 Sponsor: Protocol IDs: MDA-DM-90046, NCI-P93-0036
|
|
22.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Completed Age: 48 to 72 Sponsor: Other Protocol IDs: RUH IRB # PHO-0554, NCT00298545
|
|
23.
|
Phase: No phase specified Type: Treatment Status: Closed Age: postmenopausal Sponsor: Protocol IDs: CBCG-4401
|
|
24.
|
Phase: No phase specified Type: Prevention Status: Closed Age: 21 to 79 Sponsor: Protocol IDs: DMS-CPHS-11521, NCI-P89-0021
|
|
25.
|
Phase: No phase specified Type: Prevention Status: Completed Age: any age Sponsor: NCI Protocol IDs: SWOG-9041, NCI-P92-0031
|